Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Dicato

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Biochemical Pharmacology|May 19, 2009
The inhibition of TNF-alpha-induced NF-kappaB activation by marine natural productsFlorence Folmer, Marcel Jaspars, Godofredo Solano, et al.
Leukemia|October 31, 2023
ATP1A1/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosidesClaudia Cerella, Sruthi Reddy Gajulapalli, Anne Lorant, et al.
Cancer Letters|September 26, 2017
Tubulin-binding anticancer polysulfides induce cell death via mitotic arrest and autophagic interference in colorectal cancerEsma Yagdi Efe, Aloran Mazumder, Jin-Young Lee, et al.
Oncology|April 28, 2005
Cancer-related anemia: pathogenesis, prevalence and treatmentGunnar Birgegård, Matti S Aapro, Carsten Bokemeyer, et al.
Pharmacological Research|July 4, 2020
The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemiaHélène Losson, Sruthi Reddy Gajulapalli, Manon Lernoux, et al.
Cancer Letters|December 17, 2017
Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancerJin-Young Lee, Oualid Talhi, Dongman Jang, et al.
Clinical Epigenetics|May 21, 2020
Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cellsManon Lernoux, Michael Schnekenburger, Hélène Losson, et al.
Oncotarget|March 24, 2016
Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in cancer cellsCristina Florean, Michael Schnekenburger, Jin-Young Lee, et al.
Cell Death & Disease|February 9, 2020
Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemiaSungmi Song, Jin-Young Lee, Ludmila Ermolenko, et al.
Biomarker Research|May 4, 2024
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradationBarbora Orlikova-Boyer, Anne Lorant, Sruthi Reddy Gajulapalli, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Biochemical Pharmacology|May 19, 2009
The inhibition of TNF-alpha-induced NF-kappaB activation by marine natural productsFlorence Folmer, Marcel Jaspars, Godofredo Solano, et al.
Leukemia|October 31, 2023
ATP1A1/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosidesClaudia Cerella, Sruthi Reddy Gajulapalli, Anne Lorant, et al.
Cancer Letters|September 26, 2017
Tubulin-binding anticancer polysulfides induce cell death via mitotic arrest and autophagic interference in colorectal cancerEsma Yagdi Efe, Aloran Mazumder, Jin-Young Lee, et al.
Oncology|April 28, 2005
Cancer-related anemia: pathogenesis, prevalence and treatmentGunnar Birgegård, Matti S Aapro, Carsten Bokemeyer, et al.
Pharmacological Research|July 4, 2020
The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemiaHélène Losson, Sruthi Reddy Gajulapalli, Manon Lernoux, et al.
Cancer Letters|December 17, 2017
Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancerJin-Young Lee, Oualid Talhi, Dongman Jang, et al.
Clinical Epigenetics|May 21, 2020
Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cellsManon Lernoux, Michael Schnekenburger, Hélène Losson, et al.
Oncotarget|March 24, 2016
Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in cancer cellsCristina Florean, Michael Schnekenburger, Jin-Young Lee, et al.
Cell Death & Disease|February 9, 2020
Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemiaSungmi Song, Jin-Young Lee, Ludmila Ermolenko, et al.
Biomarker Research|May 4, 2024
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradationBarbora Orlikova-Boyer, Anne Lorant, Sruthi Reddy Gajulapalli, et al.
Pageof 16